Adlai Nortye Group Ltd. (ANL) stock
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.48−0.55 (-5.48%)
Close on Nov 17, 2026Market cap $379.20MP/E –Yield –
Adlai Nortye cash
Cash and short-term investments held at the end of each period.
Adlai Nortye's cash was $8.06M at Dec 31, 2025. For fiscal 2025 it was $8.06M, down 86.8% from the year before. The highest annual figure on record is $91.49M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.06M | -86.8% |
| FY2024 | Dec 31, 2024 | $60.90M | -33.4% |
| FY2023 | Dec 31, 2023 | $91.49M | +114.0% |
| FY2022 | Dec 31, 2022 | $42.76M | -33.3% |
| FY2021 | Dec 31, 2021 | $64.13M | +164.3% |
| FY2020 | Dec 31, 2020 | $24.26M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $8.06M | -87.4% |
| Q4 FY2024 | Dec 31, 2024 | $60.90M | +151.0% |
| Q4 FY2023 | Dec 31, 2023 | $91.49M | – |
| Q4 FY2022 | Dec 31, 2022 | $42.76M | – |
| Q4 FY2021 | Dec 31, 2021 | $64.13M | – |
| Q4 FY2020 | Dec 31, 2020 | $24.26M | – |
See a number that looks wrong?